Epsilon Healthcare Ltd (ASX: EPN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Epsilon Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $7.21 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 300.35 million
Earnings per share -0.011
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Epsilon Healthcare Ltd (ASX: EPN)
    Latest News

    a woman
    Share Fallers

    Can ASX cannabis shares rebound in 2020?

    The ASX cannabis shares have struggled to climb higher in 2020, but is there light at the end of the…

    Read more »

    a woman
    Share Gainers

    Why Adairs, Gold Road, oOh!Media, & THC Global shares are storming higher

    The Adairs Ltd (ASX:ADH) share price and the THC Global Group Ltd (ASX:THC) share price are two of four storming…

    Read more »

    a woman
    Share Gainers

    THC Global share price surges 11% higher on cannabis production update

    The THC Global Group Ltd (ASX:THC) share price is surging higher after providing an update on its cannabis production activities...

    Read more »

    a woman
    Share Fallers

    Elixinol share price slumps 6% after sale of Japanese cannabis arm

    The Elixinol Global Ltd (ASX: EXL) share price has slumped in early trade after the ASX cannabis stock sold its…

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis stock is surging higher today

    Shares in ASX cannabis stock THC Global Group Ltd (ASX: THC) are rocketing higher today after an operating update from…

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis stock rocketed 13% higher yesterday

    ASX cannabis stock THC Global Group Ltd (ASX: THC) is surging higher on the ASX this morning after receiving a…

    Read more »

    a woman
    Share Gainers

    Why THC Global and these ASX cannabis shares are rocketing higher today

    The THC Global Group Ltd (ASX:THC) share price and these cannabis shares are rocketing higher on Monday. Here's why...

    Read more »

    a woman
    Share Fallers

    Why these ASX cannabis shares were crushed in October

    Althea Group Holdings Ltd (ASX:AGH), AusCann Group Holdings Ltd (ASX:AC8), and these ASX cannabis shares were crushed in October...

    Read more »

    a woman
    52-Week Lows

    Why these ASX cannabis shares are being smoked

    The AusCann Group Holdings Ltd (ASX:AC8) share price is one of three in the cannabis industry hitting a 52-week low...

    Read more »

    a woman
    Speculative

    Weekly ASX cannabis share news

    Althea Group Holdings Ltd (ASX:AGH) shares are one of three making news in the ASX cannabis industry this week...

    Read more »

    a woman
    Share Market News

    Should you still be invested in ASX marijuana shares?

    With the main ASX marijuana stocks currently hanging around 52-week lows, is there still room for them in your portfolio?

    Read more »

    a woman
    Share Gainers

    Why has the THC share price climbed 13% in 2 days?

    The THC Global Ltd (ASX: THC) share price climbed 13% after the company emerged from its trading halt with a…

    Read more »

    EPN ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Epsilon Healthcare Ltd

    Epsilon Healthcare Ltd. manufactures and distributes hydroponics equipment, materials, and nutrients; and develops and delivers medical cannabis. The company was founded on August 29, 2016 and is headquartered on Millers Point, Australia.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Alan Preston Beasley Non-Executive DirectorNon-Executive Deputy Chairman Aug 2016
    Mr Beasley has worked in the Investment Banking and Investment Management Industries for over 30 years with BankersTrust Australia, Goldman Sacks Asset Management, BNP Paribas Asset Management Ltd. The last two positions as Managing Director and Australian Country Head. Mr Beasley is a Director and former Director of several listed and unlisted public and private companies including two public charities.
    Mr Peter Giannopoulos Chief Executive OfficerExecutive Director May 2023
    Mr Giannopoulos brings to Epsilon, more than 25 years experience across the Australian healthcare ecosystems including success within the ASX healthcare setting and success in leadership, operations, M&A, GMP manufacturing & the delivery of innovative revenue, and market accretive opportunities Most recently Peter was CEO of Cell Therapies Pty Ltd, an Australian based globally active commercial contract development and manufacturing company with a specialisation in cell and gene therapies and cellular immunotherapy products. At Cell Therapies, Peter introduced corporate strategies and controls and a trajectory for growth, including undertaking capital raising activities to support the organisation to achieve revenue growth in coming years as it capitalises on local and global manufacturing opportunities in the cell and gene therapy landscape. Prior to Cell Therapies Pty Ltd, Peter led the diversification of Australia largest private hospital provider, Ramsay Healthcare (ASX: RHC) as the CEO of the Ramsay Pharmacy Group over a 12 year period. As the executive who developed and led the expansion of the Ramsay Pharmacy Group from a single site in 2007. Peter also has a clinical background with a degree in pharmacy and a deep understanding of the Australian and international health landscapes.
    Ms Zoe Hutchings Non-Executive Director Jun 2024
    --
    Mr Richard Phillip Legge Company Secretary Aug 2024
    -
    Mr Marcelo Mora Company Secretary Dec 2022
    -
    Richard Phillip Legge Company Secretary
    -
    Marcelo Mora Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Watercrest Asset Management Pty Ltd 35,828,878 11.93%
    Fennell Church Pty Ltd 8,438,499 2.81%
    Mr Craig Graeme Chapman <Nampac Discretionary A/C> 7,500,000 2.50%
    Health360 Investment Management Inc 7,052,880 2.35%
    Cannim Group Pty Ltd 5,555,556 1.85%
    Filmrim Pty Ltd 4,465,755 1.49%
    Barcoo Holdings Pty Ltd <Wyan Family Investments> 3,795,824 1.26%
    Karantzias Investments Pty Ltd <Karantzias Family A/C> 3,636,364 1.21%
    Sckld Investments Pty Ltd <Sckld Holdings A/C> 3,593,894 1.20%
    Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 3,055,650 1.02%
    Mr George Daaboul 3,000,000 1.00%
    Meta Growth Corp 2,942,489 0.98%
    Celtic Capital Pty Ltd 2,888,872 0.96%
    Tiger Pty Ltd <Tiger Commercial Unit Trust> 2,545,455 0.85%
    Barcoo Holdings Pty Ltd <Maple Ventures> 2,438,341 0.81%
    Htgr Investments Pty Ltd 2,298,765 0.77%
    Mrs Chongna Wang 2,046,035 0.68%
    Mr Alan Roseby Barkas + Mrs Lee Margaret Barkas <Barkas Super 2,000,000 0.67%
    Mr Craig Graeme Chapman <Nampac Discretionary A/C> (i) 1,958,684 0.65%
    Citicorp Nominees Pty Limited 1,598,988 0.53%

    Profile

    since

    Note